Bora Announces Signing of Exclusive License Agreement with SSP

Bora (6472) announced signing of a new contract with SSP Co. Ltd, a leading company in the Japan pharmaceutical industry, to exclusively represent SSP’s full range of products in Taiwan. This business collaboration will strengthen Bora’s strategic planning in its people-centric consumer healthcare business in Taiwan. Bora have already taken a strong foothold in the field of over-the-counter medication, food supplements products etc. Partnering with SSP is a defining opportunity for Bora to further expand the range of products offered to Taiwanese consumers. SSP has a leading position in Japanese medicine field, such as Pain relief, nutrition supplement, oral-care and so on. EVE andチオールC etc. are some of the well-known SSP products highly popular among Taiwanese consumers.

We believe that this collaboration will benefit both business enterprises and improve health and quality of life for Taiwanese consumers through the introduction of SSP’s high-quality products. 

About SSP Co. Ltd.

SSP Co. Ltd., In the Sanofi group, has been part of Sanofi’s Consumer Healthcare business Unit since 2017. Sanofi Consumer Healthcare is part of Sanofi, a global healthcare organization, dedicated to improving the lives of people worldwide. Sanofi Consumer Healthcare is one of the top three organizations in the Consumer Healthcare market and provides consumer centric, innovative self-care solutions that are mainly tailored to four global categories: Cough & Cold and Allergy, Pain, Digestive Health and Nutritional Health. 

SSP Co., Ltd is a pharmaceutical company specializing in over-the-counter (OTC) drugs and healthcare products. Since its foundation in 1765, SSP Co., Ltd. has offered a variety of products that meet the needs of health for over 250 years.